Apparo LLC – Trademark Portfolio
Entity Type: 16
Apparo LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include APPARO and SOLISTEIN. The owner is based in Eden Prairie, MN.
17859 George Moran Drive
Eden Prairie, MN 55347
Showing of trademarks Trademarks
Trademark Classifications
Apparo LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Legal services; security services for the protection of property and individuals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Apparo LLC have?
Apparo LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Apparo LLC file in?
Apparo LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 37 (Building & Construction), Class 45 (Legal & Security Services), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Apparo LLC's most well-known trademarks?
Apparo LLC's registered trademark portfolio includes well-known marks such as APPARO and SOLISTEIN. These are among 4 currently registered trademarks in the portfolio.
What is Apparo LLC's trademark registration success rate?
Apparo LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.